All Research on Pharmaceuticals and Healthcare

Insight

Report
Report

Immuno-Oncology Overview

This is an overview of the field of immuno-oncology and the various immuno-oncology classes. Immuno-oncology is one of the most promising and fastest growing areas of cancer research.

Published By Datamonitor
$7500
Buy
Report
Report

Forecast: Rheumatoid Arthritis in the US, Japan, and 5EU

Datamonitor Healthcare uses a patient-based approach to size the rheumatoid arthritis (RA) market in the US, Japan, and five major EU markets from 2014 to 2023, focusing on traditional and biologic disease-modifying therapies.

Published By Datamonitor
$2800
Buy
Report
Report

Treatment: Rheumatoid Arthritis

Through our in-house primary research, Datamonitor Healthcare has produced thorough analysis on rheumatoid arthritis (RA) treatment trends, outcomes, and unmet needs.

Published By Datamonitor
$2800
Buy

View all Insight >>

Market Data

Interactive Model
Interactive Model

Medtrack: Musculoskeletal Disorders Pipeline Databook - May 2013

This in-depth Excel databook covers the musculoskeletal disorders pipeline by company and phase.

Published By Datamonitor
$2900
Buy
Interactive Model
Interactive Model

Medtrack: Autoimmune and Inflammation Pipeline Databook - May 2013

This in-depth Excel databook covers the autoimmune and inflammation pipeline by company and phase.

Published By Datamonitor
$2900
Buy
Interactive Model
Interactive Model

Medtrack: Cancer Pipeline Databook - May 2013

This in-depth Excel databook covers the cancer pipeline by company and phase.

Published By Datamonitor
$2900
Buy

View all Market Data >>

Profiles

Company Profile
Company Profile

Almirall S.A.

Almirall (or 'the group') is principally engaged in the research, development, storage, and commercialization of proprietary drugs as well as licensed products. Its products are sold in over 70 countries, with a direct presence in Europe, the US and Mexico. Almirall is headquartered in Barcelona, Spain, and employed about 2,130 people as of December 31, 2014.

Published By MarketLine
$175
Buy
Company Profile
Company Profile

Novo Nordisk A/S

Novo Nordisk (or 'the company') is a leading global provider of diabetes products. The company also has a leadership position in hemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk operates in Europe, North America, China, Japan, Korea and other regions of the world. It is headquartered in Bagsvaerd, Denmark, and employed 41,450 people as of December 31, 2014.

Published By MarketLine
$175
Buy
Company Profile
Company Profile

Nihon Kohden Corporation

Nihon Kohden (Nihon or 'the company') is engaged in developing, manufacturing and selling medical electronics equipment. The company operates in Asia, Americas, Europe and other regions of the world. It is headquartered in Tokyo, Japan and employed 4,495 people as of March 31, 2014.

Published By MarketLine
$175
Buy

View all Profiles >>

No help is available.